Navigation Links
The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
Date:8/23/2012

, Ph.D.,  Dana-Farber Cancer Institute, Personalizing AML therapy by BH3 profiling AML stem cells 
  • Ross Levine, M.D., Memorial Sloan-Kettering Cancer Center, Targeting cytosine hydroxymethylation in AML stem cells 
  • A. Thomas Look, M.D., Dana-Farber Cancer Institute, Targeting of nuclear export in primary AML cells 
  • Li  Zhang, MSc, M.D., Ph.D, University Health Network,  Preventing AML relapse by targeting stem cells with double-negative T-cells 
  • Novel therapeutic strategies for non-cutaneous T-cell lymphoproliferative disorders:
    • Jaroslaw Maciejewski, M.D., Ph.D., Cleveland Clinic Foundation, Implications of STAT3 Mutations in Large Granular Lymphocyte Leukemia 
    • Owen O'Connor, M.D., Ph.D., Columbia University, Epigenetic Approaches to PTCL Therapy 
  • Development of therapeutic strategies for the high risk myeloma patient:
    • Jennifer Carew, Ph.D., University of Texas Health Science Center at San Antonio, Targeting SIRT1 in Multiple Myeloma 
    • Irene Ghobrial, M.D., Dana-Farber Cancer Institute, Targeting Hypoxic and Metabolic pathways in Multiple Myeloma 
    • Christoph Heuck, M.D., University of Arkansas for Medical Sciences, Targeting DNA methylation in the diagnosis and therapy of high-risk myeloma 
    • Alexander Stewart, M.D., Mayo Clinic, Development of Novel Therapeutics Targeting High Risk Myeloma 
  • Mechanisms underlying long term and late effects resulting from cancer treatment and the development of measures to significantly reduce or prevent these toxicities
    • Smita Bhatia, M.D., M.P.H., City of Hope, Bone Marrow Transplant Survivor Study-2
    • Eric Chow, M.P.H., Fred Hutchinson Cancer Research Center, Dexrazoxane and
      '/>"/>

    SOURCE The Leukemia & Lymphoma Society
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
    2. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
    3. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
    4. MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020
    5. MarketsandMarkets: Acute Myeloid Leukemia Therapeutics Market in G8 Countries Worth $1.67 Billion by 2020
    6. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
    7. TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
    8. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
    9. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
    10. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
    11. Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/22/2014)... MI (PRWEB) November 22, 2014 ... to simulate the proper management of life-like respiratory ... test lung devices . Grand Rapids-based, Michigan Instruments ... to donate two of the respiratory simulation units ... $15,000 each. Grand Valley and Muskegon Community College ...
    (Date:11/21/2014)... The science of light and how ... more than 200 primary students in a traveling program ... of Otago Physics Department and funded by an ... of the university’s OSA/SPIE Student Chapter visited six primary ... children from small, rural schools hands-on lessons in optics ...
    (Date:11/21/2014)... (PRWEB) November 20, 2014 The November ... available as an open access journal featuring the following ... fluorescent proteins to preserve photoresponsiveness in the retina , ... fluorescent in situ hybridization using chromogenic substrates in zebrafish ... DNA, RNA, and protein electrophoresis , Nuclear ...
    (Date:11/21/2014)... DIEGO , Nov. 20, 2014 ... has been dosed in its Phase 1 trial ... cisplatin for the treatment of malignant pleural mesothelioma ... Group is conducting clinical trials on ADI-PEG 20, ... agents, for the treatment of several other indications, ...
    Breaking Biology Technology:Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 2Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 3Optics and photonics outreach programs share science, spark fascination with light 2Optics and photonics outreach programs share science, spark fascination with light 3BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2
    ... at the University of East Anglia (UEA) could contribute ... agricultural waste to generate clean electricity. Published today ... National Academy of Sciences (PNAS), the researchers have ... some bacteria survive by ,breathing rocks,. The findings ...
    ... , , COLUMBIA, Md., Dec. 16 ... results for the fourth quarter and fiscal year ended October 31, ... from $90.4 million in the fourth quarter of fiscal 2008. Net ... fourth quarter of fiscal 2009, a 5% increase compared with $10.5 ...
    ... , , LAS VEGAS, Dec. ... umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) ... biological insurance policy, to families nationwide and internationally, said today that ... so far in the fourth quarter of 2009 and total debt ...
    Cached Biology Technology:'Rock-breathing' bacteria could generate electricity and clean up oil spills 2Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3
    (Date:11/18/2014)... Nov. 17, 2014 The Parenteral Drug Association (PDA) ... agencies will speak and at least seven more will participate ... the Omni Shoreham Hotel in Washington D.C. ... to have significant support from the regulatory agencies in ... in our effort to help advance the use ...
    (Date:11/12/2014)... , Nov. 12, 2014 Crossmatch™, a ... that its U.are.U ® fingerprint readers have been ... in Central Mexico . The bakery ... to eliminate payroll issues caused by employees clocking in ... the U.are.U fingerprint readers, Montparnasse relied on paper timecards ...
    (Date:11/7/2014)... Researchers led by Dr. Debra Auguste, associate professor, ... at The City College of New York, have ... treatment for one of the most aggressive forms ... (TNBCs) have a high mortality rate owing to ... effective therapeutic options. However, Professor Auguste,s team, discovered ...
    Breaking Biology News(10 mins):FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
    ... An in-depth study by Sandia National Laboratories and ... waste and dedicated energy crops could sustainably replace nearly ... The goal of the "90-Billion Gallon Biofuel ... large volume of cellulosic biofuel could be sustainably produced, ...
    ... that road salt used throughout the winter is making ... aquatic life and drinking water. The research indicates ... judicious use of road salt could help lessen the ... a video with research team leader Heinz Stefan, go ...
    ... elevations in Arizona,s Santa Catalina Mountains as summer temperatures ... Arizona in Tucson. The flowering ranges of 93 ... to where the same species flowered the previous ten ... the region increased about 1.8 degree Fahrenheit (1 degree ...
    Cached Biology News:Biofuels can provide viable, sustainable solution to reducing petroleum dependence 2Biofuels can provide viable, sustainable solution to reducing petroleum dependence 3U of Minnesota research finds most road salt is making it into the state's lakes and rivers 2Plants take a hike as temperatures rise 2Plants take a hike as temperatures rise 3
    Donor feline serum and plasma...
    NPT1 (M-19)...
    ... is an ultra-compact pump available in single head ... ideal for use in portable air and gas ... pump works well in environments where DC operation, ... size are critical., Offers ultra-compact size, long ...
    Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
    Biology Products: